Timedora
Free Online Flashcard Deck

3 Heart Failure Medications Free Online FlashCards

Study 3 Heart Failure Medications with 12 free online flashcards. Review key terms, definitions, and concepts with this interactive flashcard deck.

12 cards
01
Front

How do heart failure medicines differ in their roles?

Back

Loop diuretics relieve congestion, while ARNI/ACE inhibitor/ARB therapy, selected beta blockers, MRAs, and SGLT2 inhibitors can improve important outcomes for appropriate patients with HFrEF.

02
Front

What is the main purpose of loop diuretics in heart failure?

Back

Loop diuretics such as furosemide increase urine output, reducing excess fluid and helping relieve swelling or breathlessness.

03
Front

What should be monitored when taking furosemide?

Back

Monitoring may include blood pressure, weight, kidney function, and electrolytes such as potassium and magnesium. Report concerning dizziness, weakness, cramps, or reduced urination.

04
Front

What is the required interval between an ACE inhibitor and sacubitril/valsartan?

Back

Do not take sacubitril/valsartan with an ACE inhibitor or within 36 hours of the last ACE-inhibitor dose; the washout helps reduce angioedema risk.

05
Front

What safety monitoring matters with sacubitril/valsartan?

Back

With sacubitril/valsartan, monitor blood pressure, kidney function, and potassium as directed. Swelling of the face, lips, tongue, or throat, or difficulty breathing, requires emergency care.

06
Front

What important electrolyte risk can spironolactone cause?

Back

MRAs such as spironolactone can raise blood potassium, particularly with kidney impairment or other medicines that raise potassium.

07
Front

What should a patient taking spironolactone do before using a potassium salt substitute?

Back

Ask the prescriber or pharmacist first. Spironolactone can raise potassium, so potassium intake, kidney function, and blood potassium need attention.

08
Front

Which beta blockers have evidence for HFrEF?

Back

Carvedilol, bisoprolol, and extended-release metoprolol succinate are the beta blockers identified as evidence-based options for HFrEF.

09
Front

How are evidence-based beta blockers generally started and adjusted?

Back

They are generally started at a low dose and adjusted as tolerated under clinical guidance, considering stability, heart rate, and blood pressure. Do not stop abruptly without advice.

10
Front

Do SGLT2 inhibitors benefit patients with HFrEF who do not have diabetes?

Back

SGLT2 inhibitors can benefit people with HFrEF whether or not they have diabetes.

11
Front

What safety concerns should be watched for with SGLT2 inhibitors?

Back

Genital infections and volume depletion are important concerns. Contact the care team about possible infection or symptoms of dehydration or low blood pressure.

12
Front

Which severe symptoms during SGLT2-inhibitor use warrant urgent assessment?

Back

Severe nausea, vomiting, abdominal pain, or trouble breathing warrants urgent medical assessment because ketoacidosis can occur, sometimes without very high blood glucose.